---
title: "CHISON MEDICAL: Currently, there are no standalone AI products sold externally, and no direct sales revenue has been generated"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/228549153.md"
description: "CHISON MEDICAL announced that there are currently no standalone AI products available for external sales, and no direct sales revenue has been generated. The company reminds investors to pay attention to investment risks and make rational decisions"
datetime: "2025-02-17T11:01:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/228549153.md)
  - [en](https://longbridge.com/en/news/228549153.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/228549153.md)
generator: "portal-rs"
---

# CHISON MEDICAL: Currently, there are no standalone AI products sold externally, and no direct sales revenue has been generated

According to the announcement from Zhitong Finance APP, CHISON MEDICAL (688358.SH) has released a notice regarding stock price fluctuations, stating that after the company's self-examination, it has noticed that some platforms have included the company's stock in the "artificial intelligence" concept stocks, and some media have regarded the company's stock as "AI medical" concept stocks, with high market attention on related concept stocks. The company provides the following explanation regarding the situation:

The company currently does not have any standalone AI products for external sales and has not directly generated sales revenue. Investors are advised to pay attention to investment risks, make prudent decisions, and invest rationally

### Related Stocks

- [688358.CN](https://longbridge.com/en/quote/688358.CN.md)

## Related News & Research

- [Junshi Biosciences terminates 2026 A-share employee stock ownership scheme](https://longbridge.com/en/news/297027904.md)
- [Officials widen lettuce-linked cyclospora outbreak probe to 20 states](https://longbridge.com/en/news/297349147.md)
- [Frontieras North America Highlights Aug. 27 Reg A+ Offering Deadline, Advances West Virginia FASForm Facility](https://longbridge.com/en/news/297213635.md)
- [Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc](https://longbridge.com/en/news/297336958.md)
- [IBA publishes H1 2026 results presentation](https://longbridge.com/en/news/297180350.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**